RESOURCE USE AND ASSOCIATED COSTS FOR METASTATIC SQUAMOUS NON SMALL CELL LUNG CANCER (SQ NSCLC) PATIENTS: A RETROSPECTIVE CHART REVIEW IN SELECT EUROPEAN COUNTRIES

被引：0
|
作者：
Lorenzo, M. [1 ]
Brown, J. [1 ]
Kurosky, S. [2 ]
Ajmera, M. R. [2 ]
Kaye, J. A. [3 ]
机构：
[1] Eli Lilly & Co Ltd, Windlesham, Surrey, England
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] RTI Hlth Solut, Waltham, MA USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2333
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN257
引用
收藏
页码：A755 / A755
页数：1
相关论文
共 50 条
  • [31] Treatment algorithms for patients with metastatic non-small cell, non-squamous lung cancer
    Melosky, Barbara
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [32] Treatment Patterns and Survival among ALK plus Non-Small Cell Lung Cancer (NSCLC) Patients: A Chart Review Study
    Park, K.
    Cadranel, J.
    Arrieta, O.
    Pless, M.
    Bendaly, E.
    Patel, D.
    Sasane, M.
    Nosal, A.
    Guerin, A.
    Kageleiry, A.
    Stein, K.
    Marinsek, N.
    Zhang, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S638 - S638
  • [33] DIRECT COSTS AND HEALTHCARE RESOURCE USE ASSOCIATED WITH ADVANCED NON-SMALL CELL LUNG CANCER MANAGEMENT IN PREVIOUSLY TREATED PATIENTS IN PORTUGAL
    Vargas Lopes, F.
    Barata, F.
    Teixeira, E.
    Almodovar, T.
    Araujo, A.
    Barroso, A.
    Brito, U.
    Hespanhol, V
    Soares, M.
    Laires, P. A.
    VALUE IN HEALTH, 2016, 19 (07) : A741 - A742
  • [34] RETROSPECTIVE LONGITUDINAL CHART REVIEW OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE NETHERLANDS: A QUANTIFICATION OF DISEASE BURDEN
    Zaim, Remziye
    Tran, Ly
    Dingemans, Anne-Marie
    Her-Der, Gerarda J.
    Lammers, Ernst
    Postmus, Pieter E.
    Uyl-De Groot, Carin A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S604 - S604
  • [35] EVALUATION OF WHITE BLOOD CELL GROWTH FACTOR (WBCGF) USE IN METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Hoverman, J. R.
    Sheth, S.
    Clayton, M.
    Garey, J.
    Beveridge, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 425 - 426
  • [36] Retrospective evaluation of chemotherapy options in non-squamous non-small cell lung cancer (non-Sq NSCLC) patients (pts) unfit for standard platinum-based chemotherapy in clinical practice
    Cortellini, A.
    Bruera, G.
    Sarno, I.
    Baldi, P. Lanfiuti
    Cannita, K.
    Dal Mas, A.
    Marchetti, A.
    Ficorella, C.
    Ricevuto, E.
    ANNALS OF ONCOLOGY, 2015, 26 : 87 - 87
  • [37] Nivolumab (NIVO) safety profile: Summary of findings from trials in patients (pts) with advanced squamous (SQ) non-small cell lung cancer (NSCLC)
    Gettinger, S. N.
    Horn, L.
    Ramalingam, S. S.
    Spigel, D. R.
    Paz-Ares, L.
    Paik, P.
    Reck, M.
    Reckamp, K.
    Mazieres, J.
    Stinchcombe, T.
    Lynch, M.
    Brahmer, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S631 - S631
  • [38] Assessment of EGFR mutations in patients diagnosed of squamous non-small cell lung cancer (NSCLC).
    Lobo, Francisco
    Domine, Manuel
    Rojo, Federico
    Izarzugaza, Yann
    Leon, Ana
    Casado, Victoria
    Jesus Fernandez-Acenero, Maria
    Rubio, Gustavo
    Ignacio Martin-Valades, Jose
    Luis Arranz, Juan
    Serrano, Gloria
    Carames, Cristina
    Cordova, Sharon
    Madoz, Juan
    Zazo, Sandra
    Rincon, Raul
    Canadas, Carmen
    Perez-Gonzalez, Nuria
    Campos, Angel
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)
    Nick Jovanoski
    Seye Abogunrin
    Danilo Di Maio
    Rossella Belleli
    Pollyanna Hudson
    Sneha Bhadti
    Libby G. Jones
    PharmacoEconomics, 2023, 41 : 1437 - 1452
  • [40] Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)
    Jovanoski, Nick
    Abogunrin, Seye
    Di Maio, Danilo
    Belleli, Rossella
    Hudson, Pollyanna
    Bhadti, Sneha
    Jones, Libby G. G.
    PHARMACOECONOMICS, 2023, 41 (11) : 1437 - 1452
12345